Gain Therapeutics, Inc. (GANX) Misses Q2 EPS by 2c

Gain Therapeutics, Inc. (NASDAQ: GANX) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Gain Therapeutics, Inc. (GANX) click here.

You May Also Be Interested In

• ADP Employment Change (Aug) 38K vs 47K Expected
• MongoDB (MDB) PT Lowered to $465 at Stifel
• Fed’s Williams says bond yields rise amid strong economy, not inflation